WisdomTree BioRevolution Fund
Limited financial coverage for WDNA.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
This fund primarily aims to meet its investment goals by employing a representative sampling method. This means it selects a portion of the securities from its benchmark index, ensuring that this smaller selection closely reflects the broader index's risk profile, expected returns, and other key characteristics. The benchmark index itself is crafted to invest in global, exchange-listed companies that are poised for significant transformation through breakthroughs in genetic research and biotechnology.
- IPO
- 2021
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on WDNA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.06M
- Div Yield
- 3.42%
- 52W High
- $24.74
- 52W Low
- $15.67
- 50D MA
- $22.56
- 200D MA
- $19.31
- Beta
- 1.26
- RSI (14)
- 53
- Avg Volume
- 2.70K
No earnings-call transcripts are available for WDNA yet.
- Free Float
- 0.0%
- Shares Outstanding
- 130.03K
- Float Shares
- 0
of shares held by institutions
3 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Nbc Securities, Inc. | 598 | 0 |
| Advisor Group Holdings, Inc. | 225 | 0 |
| Royal Bank Of Canada | 100 | ▲ 100 |
Our WDNA coverage
Recent articles, reports, and earnings notes.
No research on WDNA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WDNA report →Diverging Paths: A Look at WisdomTree's Best and Worst ETFs in Q1 2025
etftrends.com · Apr 19
Opportunities in Biotechnology Will Follow Advancements in the Science
etftrends.com · Nov 30
Why We Loved Bill Gates's Annual Letter
etftrends.com · Jan 6
Wager on WDNA for Biotech Rebound
etftrends.com · Dec 6
Multiple Reasons to Bet on Biotech ETF WDNA
etftrends.com · Sep 25
Can Health Care Stocks Outperform Again In 2023?
seekingalpha.com · Jan 11
Can Genetically Modified Crops Help With Yields, Drought And Inflation?
seekingalpha.com · Sep 29
Biden's “Cancer Moonshot” Brings Biotech Focus Back to U.S.
etftrends.com · Sep 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.